MetLife, Inc. recommends shareholders reject an unsolicited mini-tender offer by Potemkin Limited to purchase up to 10,000 shares of MetLife common stock.
The offer price of $53.00 per share is approximately 34.42% lower than the closing price of $80.82 on September 12, 2025.
MetLife advises shareholders to not tender their shares due to the offer being significantly below the current market value.
Unsolicited Offer
Potemkin Limited has made an unsolicited mini-tender offer to purchase 10,000 shares of MetLife common stock at $53.00 per share.
Price Difference
The offer price is 34.42% lower than the closing price of MetLife common stock on September 12, 2025.
Market Value
MetLife stresses that the offer is below the current market value, cautioning shareholders against tendering their shares.
- Shareholders should be cautious about Potemkin Limited's mini-tender offer, which aims to acquire shares below market prices.
- MetLife advises investors to seek current market quotations, consult with brokers, and be wary of offers that may not provide adequate investor protections.
MetLife encourages shareholders to carefully review offer documents and exercise caution in responding to Potemkin Limited's mini-tender offer. Shareholders are advised to stay informed and consider market conditions before making decisions.